10.25384/SAGE.7893434.v1 Claire Liefferinckx Claire Liefferinckx Bram Verstockt Bram Verstockt Ann Gils Ann Gils Sophie Tops Sophie Tops Wouter Van Moerkercke Wouter Van Moerkercke Severine Vermeire Severine Vermeire Denis Franchimont Denis Franchimont Supplemental material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases SAGE Journals 2019 Induction inflammatory bowel disease infliximab pharmacokinetics trough level vedolizumab wash-out 2019-03-24 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_Impact_of_first-line_infliximab_on_the_pharmacokinetics_of_second-line_vedolizumab_in_inflammatory_bowel_diseases/7893434 <p>Supplemental Material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases by Claire Liefferinckx, Bram Verstockt, Ann Gils, Sophie Tops, Wouter Van Moerkercke, Severine Vermeire and Denis Franchimont in United European Gastroenterology Journal</p>